Search - tctmd.com

Displaying 921 - 940 of 5342

Sort: Relevancy | Date

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

Are Outcome Trials Necessary for Renal Denervation Therapies?

Presenter: Ajay Kirtane

October 24, 2023

Presentation TCT 2023

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

TCT 641: Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention: a Meta-analysis of Randomized Trials

Presenter: Jayakumar Sreenivasan

October 24, 2023

Presentation TCT 2023

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

Presenter: Omar Khalique

October 24, 2023

Presentation TCT 2023

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Presenter: Nadira Hamid

October 24, 2023

Presentation TCT 2023

Importance of Patient Reported Outcomes

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

An Echo Deep Dive of the PARTNER 5-Year Study

Presenter: Philippe Pibarot

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

Perspectives on Mortality in the PARNTER 5-Year Study

Presenter: Vinod Thourani

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Presenter: Samir Kapadia

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

TCT 191: Outcomes With Intravascular Imaging-guided, Functionally Guided, or Angiography-guided Percutaneous Coronary Intervention in Patients With or Without Acute Coronary Syndromes: A Network Meta-Analysis of Randomized Trials

Presenter: Yuko Kiyohara

October 24, 2023

Presentation TCT 2023

TCT 46: Intravascular Imaging for Complex PCI: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mohamed Hamed

October 24, 2023

Advertisement

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Are Outcome Trials Necessary for Renal Denervation Therapies?

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

TCT 641: Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention: a Meta-analysis of Randomized Trials

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Importance of Patient Reported Outcomes

An Echo Deep Dive of the PARTNER 5-Year Study

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Perspectives on Mortality in the PARNTER 5-Year Study

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Four-Year Outcomes From the EVOLUT Low Risk Trial

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

TCT 191: Outcomes With Intravascular Imaging-guided, Functionally Guided, or Angiography-guided Percutaneous Coronary Intervention in Patients With or Without Acute Coronary Syndromes: A Network Meta-Analysis of Randomized Trials

TCT 46: Intravascular Imaging for Complex PCI: A Meta-Analysis of Randomized Controlled Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content